New hope for young adults whose obesity resisted lifestyle changes
Disease control
Recruiting now
This study is testing whether a medication called semaglutide can help young adults (ages 18-28) who have obesity that did not respond well to intensive lifestyle programs when they were children. About 180 participants will receive either the medication or a placebo for over a y…
Phase: PHASE4 • Sponsor: Signe Torekov • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC